Atrial Fibrillation Screening in Primary Care
Part of Heart & circulation clinical trials.
This trial tests a simple screening program in primary care to find undiagnosed atrial fibrillation (an irregular heartbeat) in people aged 65 and older. If you haven't been diagnosed with atrial fibrillation before, you may be able to help researchers see if screening works well in your community.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years old or older
- You live in a community setting (not a hospital or care facility)
- You have never been told by a doctor that you have atrial fibrillation (irregular heartbeat)
- You do not have an implantable cardioverter-defibrillator (ICD) or pacemaker
- You are able to understand and give your own consent to join
- You are not already part of another atrial fibrillation screening program
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to find hidden atrial fibrillation (an irregular heartbeat) in people aged 75-76 in the Värmland region. If caught early, treatment can help prevent strokes.
This trial tests whether extended monitoring can detect hidden atrial fibrillation (an irregular heartbeat) in people who have had a stroke. If found, treatment can help prevent another stroke.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
This study follows older adults in rural China who have atrial fibrillation (an irregular heart rhythm) to better understand the condition and screen for heart failure. Researchers want to learn more about how these conditions affect people in rural communities.
This trial tests if an electronic blood pressure monitor can detect atrial fibrillation, a common heart rhythm problem, in people aged 60 and older. It aims to make screening easier and more accessible.
This trial tests whether an artificial intelligence-enhanced ECG (called SmartECG) can detect hidden atrial fibrillation better than usual care in people who have symptoms like a racing heart or dizziness. If you qualify, you'll be randomly assigned to get the AI-enhanced test or standard monitoring, and followed to see if AF is found.
Hear when a new Atrial Fibrillation New Onset trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.